Determination of muscone in rats plasma following oral administration of artificial musk: Using of combined headspace gas chromatography-mass spectrometry

Journal of Spectroscopy

Volumn 2014, Issue , 2014, Pages

  Wu, Qibiao ^a   Li, Haitao ^b   Leng, Yujing ^b   Deng, Haishan ^b   Cheng, Haibo ^b   Shen, Weixing ^b  

^a MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAS CHROMATOGRAPHY; RATS;

GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEADSPACE GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LINEAR RELATIONSHIPS; MINIMUM DETECTABLE CONCENTRATIONS; ORAL ADMINISTRATION; PHARMACOKINETIC PROFILES; PLASMA CONCENTRATION; STABILITY AND RELIABILITIES;

PLASMAS;

ACETONITRILE; ARTIFICIAL MUSK; MUSCONE; MUSK; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG DETERMINATION; MALE; MASS FRAGMENTOGRAPHY; NONHUMAN; RAT; SENSITIVITY AND SPECIFICITY;

EID: 84897017294     PISSN: 23144920     EISSN: 23144939     Source Type: Journal    
DOI: 10.1155/2014/906928     Document Type: Article

References (10)

1. http://www.downtoearth.org.in/node/28094
2. Chan W. Y., Chau F.-T., Lee K. K. H., Kwong W. H., Yew D. T., Substitution for natural musk in Pien Tze Huang does not affect its hepatoprotective activities. Human and Experimental Toxicology 2004 23 1 35 47 2-s2.0-1342284963 10.1191/0960327104ht414oa (Pubitemid 38263156)
3. Chang H.-M., But P. P.-H., Yao S.-C., Wang L.-L., Yeung S. C.-S., Pharmacology and Applications of Chinese Materia Medica 1987 2 Singapore World Scientific
4. Lin D.-L., Chang H.-C., Huang S.-H., Characterization of allegedly musk-containing medicinal products in Taiwan. Journal of Forensic Sciences 2004 49 6 1187 1193 2-s2.0-7544228946 10.1520/JFS2003381 (Pubitemid 39453173)
5. Wei G., Chen D. F., Lai X. P., Liu D. H., Deng R. D., Zhou J. H., Zhang S. X., Li Y. W., Li H., Zhang Q. D., Muscone exerts neuroprotection in an experimental model of stroke via inhibition of the fas pathway. Natural Product Communications 2012 7 8 1069 1074
6. Li Y., Zhang J., Li L., Comparison of the therapeutic effects of different compositions of muskone in the treatment of experimental myocardial infarct in rats and analgesia in mice. Phytotherapy Research 2008 22 9 1219 1223 2-s2.0-52649146385 10.1002/ptr.2444
7. Morishita S., Mishima Y., Shoji M., Pharmacological properties of musk. General Pharmacology 1987 18 3 253 261 2-s2.0-0023110269 10.1016/0306-3623(87) 90008-5 (Pubitemid 17039251)
8. Wu Q. B., Li H. T., Wu Y., Shen W. X., Zeng L., Cheng H. B., He L., Protective effects of muscone on ischemia-reperfusion injury in cardiac myocytes. Journal of Ethnopharmacology 2011 138 1 34 39 2-s2.0-80255137143 10.1016/j.jep.2011.08.009
9. Tanaka E., Kurata N., Kohno M., Yoshida T., Kuroiwa Y., Induction of cytochrome P-450 and related drug-oxidizing activities in muscone (3-methylcyclopentadecanone)-treated rats. Biochemical Pharmacology 1987 36 24 4263 4267 2-s2.0-0023572252 10.1016/0006-2952(87)90668-X (Pubitemid 18016179)
10. Paik M.-J., Kim K.-R., Solid-phase extraction of L-muscone from aqueous samples with amberlite XAD-4 for gas chromatographic assay. Archives of Pharmacal Research 2004 27 5 539 543 2-s2.0-16544367195 10.1007/BF02980128 (Pubitemid 43080179)